Beike Biotechnology Reports on 114 Patients Treated with Novel Cord Blood Stem Cell Protocol
New Approach Opens Door to Expanded Uses of Cord Blood Stem Cells Beike Biotechnology Press Release Beiki Biotechnology and Medistem Inc (MEDS.PK) report positive safety